Literature DB >> 11867400

Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain.

Henning Harke1, Peter Gretenkort, Hans Ulrich Ladleif, Peter Koester, Salah Rahman.   

Abstract

UNLABELLED: We studied the effects of spinal cord stimulation (SCS) on postherpetic neuralgia (PHN). Data of 28 patients were prospectively investigated over a median period of 29 (quartiles 9--39) mo. In addition, four patients with acute herpes zoster (HZ) pain were studied simultaneously. After intractable pain for more than 2 yr, long-term pain relief was achieved in 23 (82%) PHN patients (median, 70 yr) during SCS treatment confirmed by a median decrease from 9 to 1 on the visual analog scale (P < 0.001). In five cases with serious comorbidity, the initial pain alleviation could not be stabilized. Spontaneous improvement was always confirmed or excluded by SCS inactivation tests at quarterly intervals. Eight patients discontinued SCS permanently because of complete pain relief after stimulation periods of 3--66 mo, whereas 2 reestablished SCS because of recrudescence after 2 and 6 mo. Considerable impairments in everyday life, objectified by the pain disability index, were also significantly improved (P < 0.001). In 4 patients with acute HZ pain, SCS was promptly effective and after periods of 2.5 (quartiles 2--3) months the pain had subsided. SCS seems to offer a therapeutic option for pharmacological nonresponders. IMPLICATIONS: In many patients with postherpetic neuralgia and acute herpes zoster pain is not satisfactorily alleviated with pharmacological approaches. We report on 23 of 28 patients with postherpetic neuralgia and 4 of 4 with acute herpes zoster whose chronic pain was improved by electrical spinal cord stimulation.

Entities:  

Mesh:

Year:  2002        PMID: 11867400     DOI: 10.1097/00000539-200203000-00040

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  29 in total

Review 1.  New Cancer Pain Treatment Options.

Authors:  Kenneth D Candido; Teresa M Kusper; Nebojsa Nick Knezevic
Journal:  Curr Pain Headache Rep       Date:  2017-02

Review 2.  WITHDRAWN: Topical lidocaine for the treatment of postherpetic neuralgia.

Authors:  Waqas Khaliq; Serena Alam; Naveen Kumar Puri
Journal:  Cochrane Database Syst Rev       Date:  2013-10-28

3.  Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy.

Authors:  Thomas J Smith; Patrick J Coyne; Gwendolyn L Parker; Patricia Dodson; Viswanathan Ramakrishnan
Journal:  J Pain Symptom Manage       Date:  2010-12       Impact factor: 3.612

Review 4.  Spinal cord stimulation in cluster headache.

Authors:  Tilman Wolter; Holger Kaube
Journal:  Curr Pain Headache Rep       Date:  2013-04

Review 5.  Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management.

Authors:  Paul J Christo; Greg Hobelmann; David N Maine
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

6.  Spinal cord stimulation for neuropathic pain: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-03-01

Review 7.  Postherpetic neuralgia: from preclinical models to the clinic.

Authors:  Ada Delaney; Lesley A Colvin; Marie T Fallon; Robert G Dalziel; Rory Mitchell; Susan M Fleetwood-Walker
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 8.  Management strategies for the treatment of neuropathic pain in the elderly.

Authors:  Mahmood Ahmad; Charles Roger Goucke
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

9.  Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.

Authors:  Ronald R White; Greg Lenhart; Puneet K Singhal; Ralph P Insinga; Robbin F Itzler; James M Pellissier; Arthur W Segraves
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Validation of a French-Canadian version of the Pain Disability Index.

Authors:  Nathalie Gauthier; Pascal Thibault; Heather Adams; Michael J L Sullivan
Journal:  Pain Res Manag       Date:  2008 Jul-Aug       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.